Article Versions Notes

Pourhassan H, Nguyen T, Yang D, Otoukesh S, Arslan S, Blackmon A, Agrawal V, Amanam I, Ball B, Koller P, et al. Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers. 2024; 16(23):3912. https://doi.org/10.3390/cancers16233912

Pourhassan, Hoda, Tina Nguyen, Dongyun Yang, Salman Otoukesh, Shukaib Arslan, Amanda Blackmon, Vaibhav Agrawal, Idoroenyi Amanam, Brian Ball, Paul Koller, and et al. 2024. "Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)" Cancers 16, no. 23: 3912. https://doi.org/10.3390/cancers16233912

Pourhassan, H., Nguyen, T., Yang, D., Otoukesh, S., Arslan, S., Blackmon, A., Agrawal, V., Amanam, I., Ball, B., Koller, P., Salhotra, A., Aribi, A., Becker, P., Curtin, P., Artz, A., Aldoss, I., Ali, H., Stewart, F., Smith, E., ... Al Malki, M. M. (2024). Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD). Cancers, 16(23), 3912. https://doi.org/10.3390/cancers16233912